ND: |
ME10680190 |
PMID: |
10680190 |
LR: |
20041117 |
CED: |
20000317 |
DCO: |
20000317 |
Autoren: |
Delafuente JC |
Titel: |
Glucosamine in the treatment of osteoarthritis. |
Quelle: |
Rheumatic diseases clinics of North America; VOL: 26 (1); p. 1-11, vii /200002/ |
PM: |
Print |
SU: |
IM |
Sprache: |
English |
CY: |
UNITED STATES |
JID: |
8708093 |
ISSN: |
0889-857X |
CO: |
RDCAEK |
Institution: |
Department of Pharmacy, School of Pharmacy, Medical College of Virginia, Virginia Commonwealth University, Richmond, USA. |
DT: |
Journal Article; Review |
RN: |
21 |
Schlagwörter |
CT: |
COMPLEMENTARY THERAPIES/*; GLUCOSAMINE/*therapeutic use; HUMANS; OSTEOARTHRITIS/*drug therapy |
CTG: |
KOMPLEMENTÄRE THERAPIEVERFAHREN/*; GLUCOSAMIN/*therapeutische Anwendung; MENSCH; OSTEOARTHROSE/*Arzneimitteltherapie |
TE: |
Glucosamine/3416-24-8 |
CR: |
3416-24-8 |
AB: |
Glucosamine sulfate, a constituent of cartilage, is evaluated for the treatment of osteoarthritis. Available data suggest that glucosamine decreases pain and improves function in osteoarthritis. Most of the glucosamine studies have methodological flaws or used parenteral formulations, making their data difficult to extrapolate into clinical practice. Glucosamine sulfate is shown to be as good as ibuprofen for osteoarthritis of the knee. Better designed clinical trials of glucosamine are needed to identify its role in the pharmacotherapy of osteoarthritis. |